DECTOMAX 10 mg/ml Solution for Injection for Cattle, Sheep and Pigs
DECTOMAX 10 mg/ml Solution for Injection for Cattle, Sheep and Pigs
Authorised
- Doramectin
Product identification
Medicine name:
DECTOMAX 10 mg/ml Solution for Injection for Cattle, Sheep and Pigs
DECTOMAX 10 MG/ML SOLUTION INJECTABLE POUR BOVINS OVINS ET PORCINS
Active substance:
- Doramectin
Target species:
-
Sheep
-
Pig
-
Cattle
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Doramectin10.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Sheep
-
Meat and offal70day
-
-
Pig
-
Meat and offal77day
-
-
-
Subcutaneous use
-
Cattle
-
Meat and offal70day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AA03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Package description:
- The product is supplied in 250 ml multi-dose Type II amber glass vials with chlorobutyl rubber stoppers and aluminium overcaps.
- The product is supplied in 500 ml multi-dose Type II amber glass vials with chlorobutyl rubber stoppers and aluminium overcaps.
- The product is supplied in 200 ml multi-dose Type II amber glass vials with chlorobutyl rubberstoppers and aluminium overcaps.
- The product is supplied in 50 ml multi-dose Type II amber glass vials with chlorobutyl rubber stoppers and aluminium overcaps.
- The product is supplied in 50 ml multi-dose Type III amber glass vials with chlorobutyl rubber stoppers and aluminium overcaps.
- The product is supplied in 200 ml multi-dose Type III amber glass vials with chlorobutyl rubberstoppers and aluminium overcaps.
- The product is supplied in 500 ml multi-dose Type III amber glass vials with chlorobutyl rubber stoppers and aluminium overcaps.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
- Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/4335418 4/2012
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0260/001
Concerned member states:
-
Austria
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Estonia
-
France
-
Greece
-
Hungary
-
Latvia
-
Lithuania
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
French (PDF)
Published on: 11/04/2024
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 7/02/2025
How useful was this page?: